Janux Therapeutics
JANX
JANX
155 hedge funds and large institutions have $1.87B invested in Janux Therapeutics in 2024 Q2 according to their latest regulatory filings, with 55 funds opening new positions, 58 increasing their positions, 33 reducing their positions, and 19 closing their positions.
Holders
155
Holders Change
+34
Holders Change %
+28.1%
% of All Funds
2.25%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
55
Increased
58
Reduced
33
Closed
19
Calls
$4.12M
Puts
$4.46M
Net Calls
-$335K
Net Calls Change
+$2.56M
Top Buyers
| 1 |
PBA
1
Paradigm Biocapital Advisors
New York
|
$65.5M |
| 2 |
EC
2
EcoR1 Capital
San Francisco,
California
|
$61.6M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$58.7M |
| 4 |
VPC
4
Vestal Point Capital
New York
|
$30.4M |
| 5 |
5
BlackRock
New York
|
$98.2M |
Top Sellers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$18.5M |
| 2 |
O
2
OrbiMed
New York
|
$125M |
| 3 |
RI
3
RTW Investments
New York
|
$0 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$65.2M |
| 5 |
5
Adage Capital Partners
Boston,
Massachusetts
|
$97.5M |
